Although the precise implications of enhanced nitrosative stress and PI3K/AKT activation upon PARK2 loss are likely to be different between cancer and PD, it is conceivable that they could promote or hinder cell survival in different disease settings. This evidence concerns the gene PRKN and Parkinson disease.